Company Financials

Legend Biotech Corporation Financials

United States dollar

business Legend Biotech Corporation Company Profile

Main Stock Listing

NASDAQ: LEGN

Market Capitalization $3.97 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -22.41
Forward PE 37.65
Price to Sales TTM $4.42
Price to Book MRQ $3.97
Enterprise to Revenue 8.19
Enterprise to EBITDA -41.09

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin -26.37%
Operating Margin -15.96%
Return on Assets TTM -6.92%
Return on Equity TTM -22.53%

Income Statement

Revenue TTM $909,044,992
Revenue per Share TTM $4.94
Quarterly Revenue Growth 70.00%
Gross Profit TTM $132,676,000
EBITDA $-181,240,000
Net Income to Common TTM $-239,700,992
Diluted EPS TTM $-1.28
Quarterly Earnings Growth YoY 69.99%

Balance Sheet

Total Cash MRQ $992,590,976
Total Cash per Share MRQ $2.69
Total Debt MRQ $
Total Debt to Equity MRQ 40.57
Current Ratio MRQ 2.87
Book Value per Share MRQ $5.48

Cash Flow

Operating Cash Flow TTM $-170,072,992
Levered Free Cash Flow TTM $-157,004,880

LEGN Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 369,379,129
Float Shares 364,580,895
Avg 10 Volume 1,655,370
Avg 30 Volume None
Shares Short 14,410,603
Short Ratio 5.44
Short % of Shares 14.91%
% Held by Insiders 1.30%
% Held by Institutions 47.32%

Stock Price Summary

Beta 0.09
Fifty Two Week Low $21.19
Fifty Two Week High $45.30
Fifty Two Week Change -61.41%
Day 50 MA $27.83
Day 200 MA $32.91

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date